NEW: No-Cost Streetwise Reports Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

The Latest Medical Devices Articles from Streetwise Reports


News Update

AI Tech Firm Provides COVID-19 Contact Tracing Solution Update

News Update
  ()
Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform. read more >

Analyst: Integrated Model Positioned to Monetize on Telehealth Emergence

Research Report
  ()
Echelon Capital Markets initiates coverage and explains why it is bullish on CloudMD Software & Services. read more >
News Update

Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists

News Update
  ()
Imagin Medical delivered two functional i/Blue™ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists. read more >

SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May

  ()
SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May. read more >

West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance

  ()
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. read more >

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

  ()
Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. read more >
News Update

Inhaled Nitric Oxide Being Tested as COVID-19 Treatment

News Update
  ()
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring. read more >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor

  ()
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEATŪ jointly with its planned health subscription service BEATŪdiabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. read more >
Showing Results: 1 to 8 of 8

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe